Shilong Han

1.6k total citations · 1 hit paper
37 papers, 1.3k citations indexed

About

Shilong Han is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Shilong Han has authored 37 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 12 papers in Cancer Research and 6 papers in Genetics. Recurrent topics in Shilong Han's work include MicroRNA in disease regulation (6 papers), Wound Healing and Treatments (5 papers) and Angiogenesis and VEGF in Cancer (5 papers). Shilong Han is often cited by papers focused on MicroRNA in disease regulation (6 papers), Wound Healing and Treatments (5 papers) and Angiogenesis and VEGF in Cancer (5 papers). Shilong Han collaborates with scholars based in China, United States and France. Shilong Han's co-authors include Maoquan Li, Weishuai Lian, Rongfeng Shi, Chuanwu Cao, Xiaoyun Xie, Xue Li, Ligong Lu, Haijun Zhang, Yinpeng Jin and Xiaoping Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Shilong Han

35 papers receiving 1.2k citations

Hit Papers

Exosomes from adipose-derived stem cells overexpressing N... 2018 2026 2020 2023 2018 100 200 300 400

Peers

Shilong Han
Yan Han China
Barrett J. Larson United States
Peipei Wu China
Erwin A. Kruger United States
Oren Z. Lerman United States
Chek Kun Tan Singapore
Shilong Han
Citations per year, relative to Shilong Han Shilong Han (= 1×) peers Yaoxiang Sun

Countries citing papers authored by Shilong Han

Since Specialization
Citations

This map shows the geographic impact of Shilong Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shilong Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shilong Han more than expected).

Fields of papers citing papers by Shilong Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shilong Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shilong Han. The network helps show where Shilong Han may publish in the future.

Co-authorship network of co-authors of Shilong Han

This figure shows the co-authorship network connecting the top 25 collaborators of Shilong Han. A scholar is included among the top collaborators of Shilong Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shilong Han. Shilong Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Qing, Shilong Han, Maoquan Li, et al.. (2025). Translational Inhibition of Slug by Pdcd4 Contributes to Invasion Inhibition in Colorectal Cancer Cells. Cancer Medicine. 14(15). e71145–e71145. 1 indexed citations
2.
Chen, Wentao, Yahong Wu, Zhen Guo, et al.. (2025). CNS Mitochondria‐Derived Vesicle in Blood: Potential Biomarkers for Brain Mitochondria Dysfunction. Annals of Clinical and Translational Neurology. 12(7). 1312–1323. 1 indexed citations
3.
Yu, Wendan, Shilong Han, Sheng Hu, et al.. (2024). KIF15 promotes human glioblastoma progression under the synergistic transactivation of REST and P300. International Journal of Biological Sciences. 20(13). 5127–5144. 4 indexed citations
4.
Hao, Jiaojiao, Jinsheng Huang, Yan Zuo, et al.. (2023). A novel TOX3-WDR5-ABCG2 signaling axis regulates the progression of colorectal cancer by accelerating stem-like traits and chemoresistance. PLoS Biology. 21(9). e3002256–e3002256. 7 indexed citations
5.
Zhang, Wei, et al.. (2023). FTO Knockdown-Mediated Maturation of miR-383-5p Inhibits Malignant Advancement of Pancreatic Cancer by Targeting ITGA3. Biochemical Genetics. 62(4). 2652–2666. 6 indexed citations
6.
Guo, Ping, Shilong Han, Wendan Yu, et al.. (2022). BPTF inhibition antagonizes colorectal cancer progression by transcriptionally inactivating Cdc25A. Redox Biology. 55. 102418–102418. 11 indexed citations
7.
Han, Shilong, Chuanwu Cao, Rui Liu, et al.. (2022). GAS41 mediates proliferation and GEM chemoresistance via H2A.Z.2 and Notch1 in pancreatic cancer. Cellular Oncology. 45(3). 429–446. 15 indexed citations
9.
Li, Wenyang, Sheng Hu, Chunfang Tian, et al.. (2021). TRIP4 transcriptionally activates DDIT4 and subsequent mTOR signaling to promote glioma progression. Free Radical Biology and Medicine. 177. 31–47. 7 indexed citations
10.
Shi, Rongfeng, Weishuai Lian, Yinpeng Jin, et al.. (2020). Role and effect of vein-transplanted human umbilical cord mesenchymal stem cells in the repair of diabetic foot ulcers in rats. Acta Biochimica et Biophysica Sinica. 52(6). 620–630. 33 indexed citations
11.
Cao, Chuanwu, et al.. (2019). <p>Downregulated Circular RNA hsa_circ_0000291 Suppresses Migration And Proliferation Of Gastric Cancer Via Targeting The miR-183/ITGB1 Axis</p>. Cancer Management and Research. Volume 11. 9675–9683. 16 indexed citations
12.
Li, Xue, Xiaoyun Xie, Weishuai Lian, et al.. (2018). Exosomes from adipose-derived stem cells overexpressing Nrf2 accelerate cutaneous wound healing by promoting vascularization in a diabetic foot ulcer rat model. Experimental & Molecular Medicine. 50(4). 1–14. 402 indexed citations breakdown →
13.
Lian, Weishuai, Xiaoxiao Hu, Rongfeng Shi, et al.. (2018). MiR-31 regulates the function of diabetic endothelial progenitor cells by targeting Satb2. Acta Biochimica et Biophysica Sinica. 50(4). 336–344. 8 indexed citations
14.
Zhang, Xiaoping, Weishuai Lian, Shilong Han, et al.. (2016). Transcatheter Arterial Infusion of Autologous CD133+ Cells for Diabetic Peripheral Artery Disease. Stem Cells International. 2016(1). 6925357–6925357. 15 indexed citations
15.
Han, Shilong, Chuanwu Cao, Tao Tang, et al.. (2015). ROBO3 promotes growth and metastasis of pancreatic carcinoma. Cancer Letters. 366(1). 61–70. 45 indexed citations
16.
Lü, Kun, et al.. (2014). Potential Study Perspectives on Mechanisms and Correlations Between Adiposity and Malignancy. Asian Pacific Journal of Cancer Prevention. 15(2). 1057–1060. 8 indexed citations
17.
Lü, Kun, Shuanshuan Xie, Shilong Han, et al.. (2014). Preparation of a nano emodin transfersome and study on its anti-obesity mechanism in adipose tissue of diet-induced obese rats. Journal of Translational Medicine. 12(1). 72–72. 40 indexed citations
18.
Han, Shilong, Xiaoping Zhang, Liling Zou, et al.. (2014). Does Drug-Eluting Bead Transcatheter Arterial Chemoembolization Improve the Management of Patients with Hepatocellular Carcinoma? A Meta-Analysis. PLoS ONE. 9(8). e102686–e102686. 24 indexed citations
19.
Fang, Pengqian, et al.. (2014). What limits the utilization of health services among the rural population in the Dabie Mountains- Evidence from Hubei province, China?. BMC Health Services Research. 14(1). 379–379. 33 indexed citations
20.
Zeng, Fan‐Gang, Hongbin Chen, & Shilong Han. (2005). Temporal Masking in Electric Hearing. Journal of the Association for Research in Otolaryngology. 6(4). 390–400. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026